A multicenter retrospective observational study to evaluate the efficacy and safety of durvalumab following concurrent chemoradiotherapy for stage III non-small cell lung cancer harboring EGFR mutation (NEJ063 study) - Trial UMIN000051670
Access comprehensive clinical trial information for UMIN000051670 through Pure Global AI's free database. This Not Applicable trial is sponsored by Tohoku University Hospital and is currently Not yet recruiting. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000051670
Not Applicable
Not yet recruiting
Trial Details
University Hospital Medical Information Network • UMIN000051670
A multicenter retrospective observational study to evaluate the efficacy and safety of durvalumab following concurrent chemoradiotherapy for stage III non-small cell lung cancer harboring EGFR mutation (NEJ063 study)
Study Focus
Observational
Sponsor & Location
Tohoku University Hospital
Japan
Timeline & Enrollment
Not Applicable
Sep 30, 2023
N/A
ICD-10 Classifications
Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung
Data Source
University Hospital Medical Information Network
UMIN000051670
Non-Device Trial